CIT Healthcare Finance served as joint lead arranger in a $135 million senior secured credit facility to support Arlington Capital Partners’ acquisition of Avalign.

Lake Forest, IL,-headquartered Avalign is a manufacturer of implants and instruments, specialty instrumentation, cutting tools, cases and trays to orthopedic medical device and specialty surgical markets. Financing was provided by CIT Bank.

“We’re pleased to lead this transaction as we put our knowledge and extensive expertise in the medical device manufacturing space to work for Arlington,” said William Douglass, group head and managing director of CIT Healthcare Finance. “Avalign is focused on serving the growing $36 billion global orthopedic market, serving OEM customers who supply highly demanded technologies to the industry’s fastest growing end-markets, including extremities, sports medicine and trauma.”